Healthcare Innovation Surge: GE HealthCare, VA, and Function Lead Transformation with AI and Cloud Tech
A wave of innovation is sweeping across the healthcare landscape, driven by strategic acquisitions, artificial intelligence, and new business models. On Thursday, November 20, 2025, GE HealthCare announced a $2.3 billion deal to acquire Intelerad, while the Department of Veterans Affairs expands its AI-powered scribe technology and Function secures a $2.5 billion valuation. These developments signal a significant shift toward more efficient, accessible, and data-driven patient care.
GE HealthCare to Bolster Enterprise Imaging with Intelerad Acquisition
GE HealthCare is set to significantly expand its capabilities in cloud-enabled enterprise imaging with the acquisition of Intelerad, a leading medical imaging software vendor. The $2.3 billion deal, announced today, aims to streamline image management and access across diverse care settings. According to a company release, the integration of Intelerad’s technology will allow GE HealthCare to offer a more comprehensive suite of solutions, enhancing diagnostic accuracy and improving workflow efficiency for clinicians.
“This acquisition is a strategic move to position GE HealthCare at the forefront of the evolving imaging landscape,” one analyst noted. “The demand for cloud-based imaging solutions is rapidly increasing, and this deal allows GE HealthCare to capitalize on that trend.”
VA Leverages AI to Enhance Veteran Care Experience
The Department of Veterans Affairs (VA) is actively deploying artificial intelligence (AI) to improve the experience for veterans receiving care. The VA is currently piloting ambient AI scribe technology at 10 medical centers, with plans for full implementation across all facilities by 2026. This technology automatically generates clinical documentation during patient encounters, freeing up physicians to focus on direct patient care.
A senior official stated that the AI scribe technology has already demonstrated promising results in reducing administrative burden and improving the accuracy of medical records. The VA’s commitment to AI underscores its dedication to providing cutting-edge healthcare services to veterans.
Function Redefines Lab Testing with $2.5 Billion Valuation
Function, a company offering direct-to-consumer lab test memberships, has achieved a significant milestone with a $298 million Series B funding round, resulting in a $2.5 billion valuation. This influx of capital will fuel the launch of Function’s Medical Intelligence Lab, dedicated to advancing personalized health insights through data analysis.
Function’s model challenges traditional lab testing by providing affordable and accessible options for individuals seeking proactive health management. The company’s success reflects a growing consumer demand for greater control over their health data and a shift toward preventative care.
These three developments – the GE HealthCare-Intelerad deal, the VA’s AI initiative, and Function’s funding round – collectively demonstrate a powerful momentum toward a more innovative and patient-centric healthcare future. The convergence of cloud technology, artificial intelligence, and new business models is poised to reshape the industry, ultimately leading to better outcomes and a more efficient healthcare system.
